La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Alignment Healthcare a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Alignment Healthcare..

Alignment Healthcare (NASDAQ:ALHC) Azioni, Catena delle Opzioni

Alignment Healthcare

Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.

Alignment Healthcare, Inc. - Common Stock

Alignment Healthcare Inc

Trading Ideas

XChange TEC.INC Shares Halted On Circuit Breaker To The Upside, Stock Now Up 118.4%

Wells Fargo analyst Matthew Akers maintains Lockheed Martin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) with a Equal-Weight and lowers the price target from $543 to $500.

News

Price Target

Analyst Ratings

Wells Fargo Maintains Equal-Weight on Lockheed Martin, Lowers Price Target to $500

Wells Fargo analyst Matthew Akers maintains General Dynamics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GD#NYSE">GD</a>) with a Equal-Weight and lowers the price target from $295 to $279.

Wells Fargo Maintains Equal-Weight on General Dynamics, Lowers Price Target to $279

DatChat Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DATS#NASDAQ">DATS</a>) shares are trading lower by 63.9% to $3.22 during Wednesday&#8217;s session after the company announced the pricing of a <a href="https://www.benzinga.com/pressreleases/25/01/g42873083/datchat-inc-announces-pricing-of-5-1-million-registered-direct-offering-priced-at-the-market-under">$5.1 million registered direct offering</a> priced at-the-market under Nasdaq rules.
DatChat announced it has entered into agreements with institutional investors for a direct offering of 1.2 million shares of common stock at $4.25 per share. The offering is expected to close on January 10, pending customary conditions. 
Benchmark Company, LLC is serving as the sole placement agent. The offering is projected to generate gross proceeds of approximately $5.1 million, which the company plans to allocate toward working capital and general corporate expenses.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42873182/us-private-businesses-add-122000-jobs-in-december-the-labor-market-downshifted-to-a-more-modest-pace-of-growth">US Private Businesses Add 122,000 Jobs In December: &#8216;Slowdown In Both Hiring And Pay Gains&#8217;</a>
<h2 class="wp-block-heading">Should I Sell My DATS Stock?</h2>
Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.
Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold.
For analysis tools, charting data and access to exclusive stock news, check out <a href="https://pro.benzinga.com/">Benzinga PRO. Try it for free.</a> 
DATS has a 52-week high of $9.34 and a 52-week low of $1.01.

DATS

Why DatChat (DATS) Stock Is Getting Hammered

Macro Economic Events

Politics

Global

Economics

General

Mexico President Says We Are Going To Collaborate With Trump Government, When Asked About Bilateral Relationship After Trump Comments

On Wednesday, Jasper Therapeutics, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JSPR#NASDAQ">JSPR</a>) reported preliminary data from the ongoing BEACON Phase 1b/2a study of subcutaneous briquilimab in adult participants with chronic <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g42869894/jasper-therapeutics-reports-positive-data-from-beacon-study-of-briquilimab-in-chronic-spontaneous-" rel="noreferrer noopener">spontaneous urticaria (CSU)</a>.
Chronic spontaneous urticaria is defined by the&nbsp;presence of hives daily or almost daily for at least six weeks.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/10/41312966/why-is-chronic-disease-focused-jasper-therapeutics-stock-trading-higher-on-monday" rel="noreferrer noopener">Why Is Chronic Disease-Focused Jasper Therapeutics Stock Trading Higher On Monday?</a>
The Urticaria Activity Score (UAS)&nbsp;assesses daily pruritus (itchy feeling) and the number of hives, which, when summed over a week, gives UAS7.
Substantial reductions in UAS7 were reported, with a mean change from baseline at 8 weeks of -26.6 in the 240mg (n=3) single-dose cohort and multiple dosing regimens at or above 120mg demonstrating UAS7 changes of more than -25 points.
Clinical responses were observed as early as one week after the first dose, and Complete Responses (UAS7 = 0) were achieved by patients at each therapeutic dose level (80mg, 120mg, 180mg, and 240mg). Most notably, all patients in the 240mg single-dose cohort maintained Complete Responses through the 8-week time point.
The durability of response was generally dose-dependent, and reductions in serum tryptase to levels below the lower limit of quantification were observed at multiple dose levels. Briquilimab was well tolerated in the study and had a favorable safety profile.
Tryptase levels below the lower limit of quantification were reported for 86% (6 of 7) of participants in the 180mg Q8W cohort at week 2 and for 100% (3 of 3) of participants in the 240 mg single-dose cohort at week 1.
Briquilimab was well tolerated in the study, with no dose-limiting toxicities observed.
Jasper expects to begin a registrational program in CSU, with a Phase 2b study expected to commence in the second half of 2025.
Additional data at 180mg Q8W from the open-label extension study, as well as further data from BEACON cohorts evaluating a 360mg single dose, a 240mg Q8W dose, and a 180mg Q8W dose following a 240mg loading dose, will inform the final selection of doses for the Phase 2 b study.
Data from these additional cohorts are expected to be presented by mid-2025.
William Blair reports that the top-line results show strong efficacy across different dose groups, possibly outperforming Celldex Therapeutics, Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLDX#NASDAQ">CLDX</a>) barzolvolimab.
However, the 180 mg dose performed below expectations, and detailed data on key adverse events by dose level is missing. Analyst Matt Phipps believes more clarity on these issues could ease investor concerns, as the stock faced significant declines.
Price Action: JSPR stock is down 59% at $7.39 at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42872581/microns-7-billion-bet-on-ai-driven-memory-singapore-facility-set-to-boost-innovation-and-jobs" target="_blank" rel="noreferrer noopener">Micron&#8217;s $7 Billion Bet on AI-Driven Memory In Singapore Facility Set to Boost Innovation</a></li>
</ul>

Analyst Color

Biotech

Health Care

Movers

CLDX

Jasper Therapeutics, Inc. - Class A Common Stock

JSPR

Jasper Therapeutics Skin Disorder Candidate Data Fails To Cheer Investors

MTNB

Matinas Biopharma Shares Resume Trade

Watching DoubleVerify; Traders Circulate Stifel Note Saying "We've Learned That DoubleVerify Is Raising Prices By Roughly 5% On Average (Pricing Ranges From Unchanged To +8 To +10%, Depending On The Product), Effective February 1st"

Wells Fargo analyst Michael Blum maintains Sunrun (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) with a Overweight and lowers the price target from $15 to $12.

Wells Fargo Maintains Overweight on Sunrun, Lowers Price Target to $12

Wells Fargo analyst Praneeth Satish maintains Sunnova Energy Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>) with a Equal-Weight and lowers the price target from $8 to $4.

NOVA

Wells Fargo Maintains Equal-Weight on Sunnova Energy Intl, Lowers Price Target to $4

Shares of e-commerce company eBay Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>) are trading higher on Wednesday after Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) said it is rolling out a new test that will integrate listings from eBay <a target="_blank" href="https://about.fb.com/news/2024/11/our-response-to-the-european-commissions-decision-on-facebook-marketplace/" rel="noreferrer noopener">directly on Facebook Marketplace</a>.
This initiative will initially launch in Germany, France, and the U.S.
Through this collaboration, eBay sellers will gain access to a wider audience on Facebook, while Marketplace users will have the opportunity to explore an expanded selection of products from eBay&#8217;s vast network.
Transactions will still be completed through eBay, maintaining the integrity of each platform&#8217;s ecosystem.
By merging listings from two major platforms, Facebook Marketplace aims to enhance user experience while allowing eBay sellers to tap into Facebook&#8217;s extensive user base.
Also Read: <a target="_blank" href="https://www.benzinga.com/tech/25/01/42861519/nvidia-unveils-ai-powered-digital-twin-tech-for-warehouse-operations" rel="noreferrer noopener">NVIDIA Unveils AI-Powered Digital Twin Tech For Warehouse Operations</a>
This move is in response to European Commission&#8217;s recent decision that Facebook Marketplace hindered competition in the European Union&#8217;s online marketplace sector.
EU regulators contended that Facebook&#8217;s parent company is linking its free Marketplace services with the social network to <a target="_blank" href="https://www.benzinga.com/markets/equities/24/09/40919557/meta-braces-for-costly-eu-fine-over-marketplace-report" rel="noreferrer noopener">disadvantage its competitors</a>.
Meta continues to appeal the ruling, highlighting that it built Facebook Marketplace to meet consumer demand and provide a new choice among European buyers.
Facebook Marketplace was launched in 2016 to provide an easy-to-use way to discover, buy, and sell items at no charge. Despite the European Commission&#8217;s claims, Meta asserts that no evidence of harm to competitors exists, pointing to the ongoing success of other major players such as eBay and Leboncoin.
Price Action: EBAY shares are trading higher by 11.8% at $70.66 at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42852041/microsoft-expands-ai-investment-in-india-with-3b-boost-report" target="_blank" rel="noreferrer noopener">Microsoft Bets Big On India&#8217;s AI Future With $3B Investment</a></li>
</ul>
Image via Shutterstock.

Equities

Tech

EBAY

eBay Stock Surges After Meta Launches Integration Test For Facebook Marketplace

WIIM

Plains All American shares are trading higher after the company announced multiple acquisitions and increased its distribution.

Wells Fargo analyst Michael Blum maintains SolarEdge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) with a Equal-Weight and lowers the price target from $19 to $15.

SEDG

Wells Fargo Maintains Equal-Weight on SolarEdge Technologies, Lowers Price Target to $15

Susquehanna analyst Charles Minervino maintains Textron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TXT#NYSE">TXT</a>) with a Positive and lowers the price target from $100 to $90.

Susquehanna Maintains Positive on Textron, Lowers Price Target to $90

Matinas BioPharma Shares Halted To The Downside; Stock Now Up 3.15%

LRHC

La Rosa Holdings Shares Halted On Circuit Breaker To The Downside, Stock Now Down -23.7%

Wells Fargo analyst Praneeth Satish maintains NEXTracker (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXT#NASDAQ">NXT</a>) with a Overweight and lowers the price target from $70 to $69.

Wells Fargo Maintains Overweight on NEXTracker, Lowers Price Target to $69

Susquehanna analyst Charles Minervino maintains RTX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) with a Positive and lowers the price target from $150 to $139.

Susquehanna Maintains Positive on RTX, Lowers Price Target to $139

According to Robb Report, the Beverly Hills residence of the late Brian Goldner, the former Hasbro chairman and CEO who transformed the toy giant into an entertainment powerhouse, is on the market for $27 million.
Goldner, who died of cancer in 2021 at age 58 and his wife Barbara acquired the 1980s-era home in 2020 for about $18 million.
Renowned interior designer Michael S. Smith, known for his work on the Obama White House, reimagined the traditional-style home. The residence spans nearly 7,500 square feet across two levels and has five bedrooms, eight bathrooms and luxurious living spaces.
Don't Miss:
<ul>
<li>Unlock the hidden potential of commercial real estate —<a href="https://equitymultiple.com/benzinga?invite=benzinga&amp;utm_campaign=product-promotion-earn&amp;utm_source=yahooFinance&amp;utm_medium=affiliate&amp;utm_content=unlockboost-yahoo"> This platform allows individuals to invest in commercial real estate offering a 12% target yield with a bonus 1% return boost today!</a></li>
<li>This Jeff Bezos-backed startup will allow you to <a href="https://arrivedhomes.go2cloud.org/aff_c?offer_id=15&amp;aff_id=1006&amp;aff_sub=yahoo&amp;aff_sub2=byerscta100">become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.</a></li>
</ul>
Antonio Bruno of Sotheby's International Realty-Beverly Hills Brokerage and Tomer Fridman of Christie's International Real Estate handle the listing.
The secluded estate, nestled in the coveted Flats neighborhood, sits on nearly half an acre of manicured grounds, fully enclosed by walls and gates. A sage-green front door beckons entry into the residence, featuring a mansard roof and a striking façade of white brick and stucco.
The grand entrance's double-height foyer is adorned with a sweeping iron-railed staircase that ascends toward a sky-lit ceiling.
See Also: During market downturns, investors are learning that unlike equities, these<a href="https://www.benzinga.com/money/connect-invest-real-estate-notes-y2"> high-yield real estate notes that pay 7.5% &#8211; 9% are protected by resilient assets, buffering against losses.</a>
The living room&#8217;s centerpiece is a veined-marble fireplace and the gourmet kitchen features a central island, a high-end Caliber range and a cozy breakfast nook. A wood-paneled office provides a dedicated workspace and the large primary suite includes a fireplace, a separate office and dual baths.
The outdoor oasis features a lush, hedge-lined backyard with a pool, spa and Baja shelf. A built-in barbecue and fireplace in a pergola-shaded lounge area create a perfect setting for outdoor entertaining. A versatile guesthouse/cabana is currently used as a home gym.
As first reported by Mansion Global, the Goldner family is relocating outside of California. Barbara Goldner, a clinical social worker, also owns property in Rhode Island.
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl-y2"> you can become an investor for $0.80 per share today.</a>
Brian Goldner, a visionary leader in the<a href="https://www.benzinga.com/money/best-toys-to-collect-for-investment"> toy industry</a>, joined<a href="https://www.benzinga.com/quote/HAS"> Hasbro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAS#NASDAQ">HAS</a>) in 2000 and rapidly ascended to the CEO position in 2008 and board chairman in 2015. Under his leadership, Hasbro evolved from a traditional toy company into a global leader in play and entertainment.
Goldner spearheaded a strategic vision to create world-class play and storytelling experiences, expanding the company's reach beyond toys and games into television, movies, digital gaming and other entertainment sectors. The transformative strategy culminated in the 2019 acquisition of eOne, an independent entertainment studio.
Goldner also served on the ViacomCBS board of directors and chaired its compensation committee.
Read Next:
<ul>
<li>Commercial real estate has historically outperformed the stock market, and<a href="https://equitymultiple.com/benzinga?invite=benzinga&amp;utm_campaign=product-promotion-earn&amp;utm_source=yahooFinance&amp;utm_medium=affiliate&amp;utm_content=stockmarket-yahoo"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a></li>
<li><a href="https://www.benzinga.com/go/arrived-private-credit-yf">Arrived Home's Private Credit Fund&#8217;s has historically paid an annualized dividend yield of 8.1%&#x2A;</a>, which provides access to a pool of short-term loans backed by residential real estate with just a $100 minimum.<a href="https://www.benzinga.com/go/arrived-private-credit-yf"> </a></li>
</ul>

Real Estate

$27 Million Price Tag For Late Hasbro CEO's Beverly Hills Oasis

BlackRock, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) will release earnings results for its fourth quarter, before the opening <a href="https://www.benzinga.com/quote/BLK/earnings">bell on Wednesday, Jan. 15, 2025.</a>
Analysts expect the company to report quarterly earnings at $11.38 per share, up from $9.66 per share in the year-ago period. BlackRock projects to report revenue of $5.63 billion for the recent quarter, compared to $4.63 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Dec. 3, the company disclosed a definitive agreement to acquire HPS Investment Partners for around $12 billion.
BlackRock shares fell 3.2% to close at $980.76 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Rating</a>s page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/BLK/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Wells Fargo analyst Michael Brown maintained an Overweight rating and slashed the price target from $1,200 to $1,155 on Jan. 7, 2025. This analyst has an accuracy rate of 70%.</li>
<li>Citigroup analyst William Katz maintained a Buy rating and boosted the price target from $1,150 to $1,200 on Dec. 23, 2024. This analyst has an accuracy rate of 67%.</li>
<li>Morgan Stanley analyst Mike Cyprys maintained an Overweight rating and raised the price target from $1,245 to $1,261 on Dec. 20, 2024. This analyst has an accuracy rate of 63%.</li>
<li>Barclays analyst Benjamin Budish maintained an Overweight rating and raised the price target from $1,120 to $1,220 on Dec. 9, 2024. This analyst has an accuracy rate of 81%.</li>
<li>Evercore ISI Group analyst Glenn Schorr maintained an Outperform rating and raised the price target from $1,040 to $1,160 on Nov. 7, 2024. This analyst has an accuracy rate of 77%.</li>
</ul>
Considering buying BLK stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="580" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08033901/image-37-1024x580.png" alt="" class="wp-image-723356" style="width:576px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08033901/image-37-1024x580.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08033901/image-37-300x170.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08033901/image-37-768x435.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08033901/image-37.png 1132w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:<a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/42846607/bank-of-new-york-mellon-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call"> </a>
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/42846607/bank-of-new-york-mellon-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Bank of New York Mellon Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>

Earnings

Markets

BlackRock Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.&nbsp; 1. STOCK NEWS: Shares of Domino's Pizza (DPZ) w...

Berkshire reveals stake in Domino's, Alibaba reports mixed Q2: Morning Buzz

Clover Health: Buy The Dip, Reap The Rewards

Health insurers spike as Trump picks Dr. Oz to head Medicare

Trump picks surgeon Marty Makary to head FDA, Rep. Dave Weldon to lead CDC

Alignment Health Plan announced that members enrolled in its HMO plans in Maricopa County now have access to over 4,500 primary care providers, spe...

Alignment Health Plan announces enhanced agreement with Arizona Priority Care

The latest update is out from Alignment Healthcare ( ($ALHC) ). Alignment Healthcare, Inc. has successfully raised $330 million through the sale of...

Alignment Healthcare's Strategic Financial Maneuvers in 2029

Biden administration proposes expanded obesity drug coverage under Medicare, Medicaid

Stephens upgraded Alignment Healthcare (ALHC) to Overweight from Equal Weight with a price target of $17, up from $13. Alignment's competitive adva...

Alignment Healthcare upgraded to Overweight from Equal Weight at Stephens

Unusual total active option classes on open include: Alignment Healthcare (ALHC), Navitas Semiconductor (NVTS), JetBlue (JBLU), AES Corp. (AES), Pl...

Unusually active option classes on open December 4th

Stephens analysts presented the firm's 2025 Best Ideas list, which includes Valley National (VLY), CoStar Group (CSGP), Castle Biosciences (CSTL), ...

Stephens lays out 21 Best Ideas for 2025

ABBV

ALHC

AMAT

AMGN

AMZN

ANDE

ASTS

AVGO

AZTA

BABA

BIIB

BMRC

BPMC

CASI

CGNX

CLOV

CPNG

CSGP

CSTL

CVNA

DESP

GILD

HALO

HIMS

JBLU

MATX

MRNA

NVTS

PRVA

RCAT

ROKU

SLGL

SNOW

SNYNF

SSNLF

STKL

TRUG

TWLO

VKTX

WING

Press Releases

Alignment Healthcare Reports Third Quarter 2024 Results

Alignment Health Plan Named a "Best" Medicare Advantage Insurer in North Carolina by U.S. News & World Report for Third Consecutive Year

Alignment Health Plan Named a "Best" Medicare Advantage Insurer in Arizona by U.S. News & World Report

Alignment Health Plan Named a "Best" Medicare Advantage Insurer in California by U.S. News & World Report

Alignment Health Plan Named a "Best" Medicare Advantage Insurer in Nevada by U.S. News & World Report

Alignment Healthcare to Present at UBS Global Healthcare Conference and Stephens Annual Investment Conference

Financing

Alignment Healthcare Announces Private Convertible Senior Notes Transaction

Alignment Health Plan Expands Access to Care in Arizona through Enhanced Agreement with Arizona Priority Care

Alignment Healthcare to Present at the 43rd Annual J.P. Morgan Healthcare Conference

UPDATE – Alignment Healthcare to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Comments

Alignment Healthcare

Alignment Healthcare (ALHC) Opzioni

Alignment Healthcare (NASDAQ:ALHC) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO